John Markman
Vice President, Global Pain Eli Lilly
John Markman, MD, FAAN, is the Global Vice President for Neuroscience and Pain at Eli Lilly. Previously, he was Vice Chair and Professor of Neurosurgery and Neurology at the University of Rochester School of Medicine. He has received the AAN’s Mitchell Max Scientific Award and served on editorial boards of the Journal of Pain and Pain Medicine. He has held leadership roles in the IASP, APS, NANS, and the American Academy of Neurology. He has also been a technical expert for the CDC, AHRQ, FDA, and NIH, focusing on his clinical experience and analgesic research.
Seminars
Thursday 28th January 2027
From Metabolic Health to Pain Relief: Assessing the Role of GLP-1 Therapies in Musculoskeletal Pain
11:00 am
- Exploring the mechanisms through which GLP-1 therapies may influence pain, inflammation, and physical function
- Examining emerging clinical evidence supporting incretin-based approaches in musculoskeletal disorders
- Applying lessons from recent trials to better evaluate efficacy in pain indications
- Improving assay sensitivity and clinical trial execution to accelerate development of next-generation
